This announcement is a separate document:
上海君澜律师事务所关于浙江海正药业股份有限公司2021年限制性股票激励计划解除限售相关事项之法律意见书
Legal Opinion on the Removal of Restrictions on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Restricted Stock Incentive Plan for 2021 by Shanghai Junlan Law Firm.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.